1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Global Diabetes Diagnostics Industry

Global Diabetes Diagnostics Industry

  • September 2020
  • 609 pages
  • ID: 4368322
  • Format: PDF
  • Global Industry Analysts


Table of Contents


Timely market intelligence is paramount in these uncertain times!

We launched an impact survey to update this project with timely insights during 2020. Update frequency will depend upon evolving market conditions and executive opinions. Our participants are executives driving strategy, marketing, sales and product management at competitive companies worldwide. All updates during the rest of the year are complimentary to clients!

Diabetes is the Largest Epidemic in Human History Surpassing Even the Black Death of the 14th Century. Diabetes Diagnostics to Reach a Colossal $45.6Billion

The global market for Diabetes Diagnostics is projected to reach US$45.6billion by the year 2027, trailing a post COVID-19 CAGR of 8.1% over the analysis period 2020 through 2027. Wiping out over 20% of the world’s population in the 14th century, "Black Death" was the most devastating pandemics in human history. Today type 2 diabetes is gradually emerging into an epidemic much bigger than Black Death. The disease will continue to grow driven by the growing incidence of diabetes in parallel to obesity and the ensuing rise of "diabesity" as a global epidemic; improper lifestyle patterns and the resulting increase in risk factors even among non-obese population. The diagnosis and treatment of diabetes have always been challenging for both the healthcare providers and the patients. Keeping up with regular exercises, diabetic meal plans, medications, and check on blood sugar levels are never easy. Diabetic patients need continuous self-management on a regular basis. It is also a tedious task for the doctors to analyze blood sugar fluctuations and other factors involved in diabetes care. Further in developing economies, managing diabetes and the complications associated with it is a big challenge due to issues such as lack of healthcare professionals, limited access to healthcare facilities, lack of awareness among people and lack of information that enables therapeutic decision-making.

All these problems contribute to missed diagnosis and delayed visits to the clinics. However, technological advancements are anticipated to solve these problems to a great extent. Advancements in the food and information technologies have revolutionized the diagnosis and treatment of diabetes. Amid the ongoing COVID-19 situation, technology seems to be provided with a chance to prove its worth more than ever before. With the latest technologies in healthcare sector such as food trackers, health apps, glucometers and pedometers, tracking of data has become easy to manage. Technology is expected to bring latest developments particularly during the COVID-19 times, where social distancing is the new norm. Introduction of glucometers, EMRs, mobile apps and digital clinics has made data tracking and lifestyle change much easier. Other technologies such as social media educate and motivate the diabetic patients to bring a change in their lifestyle. The market especially stands to benefit from the rapid advances being made in the field of continuous glucose monitoring such as smart predictive algorithms for automated control; growing understanding of diabetes pathophysiology and the resulting development of more potent disease prevention, control and management strategies; focus on diabetes self-management and research interest in the development of diabetes tracking wearable devices; growing revenue opportunity for mHealth solutions for diabetes diagnosis; launch of implantable continuous glucose monitor and cloud-enabled CGM devices; rising popularity of near patient testing and the resulting demand for HbA1c devices and encouraging research breakthroughs in "artificial pancreas".

Another worrisome trend positively influencing growth in the market is the increasing incidence of diabetes in children and the resulting focus on shed on timely screening, diagnosis and therapy administration among pediatric patients. Mainstream adoption universal screening for gestational diabetes mellitus (GDM) will also drive revenue opportunities in the market. Asia-Pacific ranks as the fastest growing market led by grim risk population analysis attributable to rapid urbanization, growing affluence and nutrition transition, less physically demanding lifestyles, high prevalence of smoking, alcohol abuse, heavy consumption of refined carbohydrates, lack of exercise and over nutrition. India and China represent the epicenter of the diabetes epidemic with both the countries recording the highest number of diabetics in the region. For long, genes, lifestyle & behavioral change have been in the spotlight as risk factors for developing type 2 diabetes. Currently, epigenetic changes are emerging to be forefront as a possible reason for the rising incidence of type 2 diabetes. While treatment regimes are evolving, routine testing has and will continue to remain vital in effective diabetes management. There is an acute need for easy-to-use, efficient, accurate and affordable solutions for effective management of the disease; and technology innovation and development of non-invasive techniques to simplify regular glucose testing. The most popular home diagnostic device is the blood glucose monitor that assists in detecting the amount of glucose present in blood. A special coated strip containing blood sample is inserted into the machine, which consequently yields results on a digital display. Certain blood glucose monitors are also equipped with a memory component capable of holding multiple test results. Analog glucose monitors are traditional blood glucose meters that uses a blood sample drawn from pricking a patient’s finger.

Competitors identified in this market include, among others,
  • A.Menarini Diagnostics Ltd.
  • Abbott Diabetes Care Inc.
  • Acon Laboratories Inc.
  • AgaMatrix Inc.
  • Apex Biotechnology Corporation
  • ARKRAY Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Beckman Coulter Inc.
  • Becton, Dickinson and Company
  • BIONIME Corporation
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • DexCom Inc.
  • Diazyme Laboratories Inc.
  • EKF Diagnostics Holdings Plc
  • HemoCue® AB
  • LifeScan, Inc.
  • Medtronic PLC
  • Nova Biomedical Corporation
  • OSANG Healthcare Co. Ltd.
  • PTS Diagnostics
  • Sanofi S.A.
  • Sanwa Kagaku Kenkyusho Co Ltd.
  • Siemens Healthineers
  • Sinocare Inc.
  • TaiDoc Technology Corporation
  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Tosoh Bioscience Inc.
  • Trinity Biotech plc
  • Trividia Health Inc.
  • Ypsomed AG

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Global Omega-3 Market - Analysis By Type, By Source, By Application, By Region, By Country : Market Insights, Covid-19 Impact, Competition and Forecast (2020-2025)

  • $ 2400
  • October 2020
  • 200 pages

Executive Summary Global Omega-3 Market was valued at USD 1512.32 million in the year 2019. Rising prevalence of life threatening and gastrointestinal diseases, augmented awareness of benefits associated ...

  • World
  • APAC
  • Dietary Supplement
  • Healthcare
  • Industry analysis
  • Diabetes Prevalence
  • Health Expenditure


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on